Literature DB >> 24366910

BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.

Angela C Hirbe1, Melike Pekmezci, Sonika Dahiya, Anthony J Apicelli, Brian A Van Tine, Arie Perry, David H Gutmann.   

Abstract

Entities:  

Keywords:  MPNST; NF1; microarray; sarcoma

Mesh：

Substances：

Year:  2013        PMID： 24366910      PMCID： PMC3922521          DOI： 10.1093/neuonc/not248

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  15 in total

1.  BRAF-V600E mutation in pediatric and adult glioblastoma.

Authors:  Sonika Dahiya; Ryan J Emnett; Devon H Haydon; Jeffrey R Leonard; Joanna J Phillips; Arie Perry; David H Gutmann
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

2.  Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.

Authors:  T N Basu; D H Gutmann; J A Fletcher; T W Glover; F S Collins; J Downward
Journal:  Nature       Date:  1992-04-23       Impact factor: 49.962

3.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases.

Authors:  B S Ducatman; B W Scheithauer; D G Piepgras; H M Reiman; D M Ilstrup
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

4.  BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper.

Authors:  Fausto J Rodriguez; Azra H Ligon; Iren Horkayne-Szakaly; Elisabeth J Rushing; Keith L Ligon; Natalie Vena; Denise I Garcia; J Douglas Cameron; Charles G Eberhart
Journal:  J Neuropathol Exp Neurol       Date:  2012-09       Impact factor: 3.685

5.  Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.

Authors:  J E DeClue; A G Papageorge; J A Fletcher; S R Diehl; N Ratner; W C Vass; D R Lowy
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

6.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Authors:  D G R Evans; M E Baser; J McGaughran; S Sharif; E Howard; A Moran
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

7.  International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.

Authors:  Rosalie E Ferner; David H Gutmann
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

8.  Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing.

Authors:  Emeline Colomba; Zofia Hélias-Rodzewicz; Andreas Von Deimling; Cristi Marin; Nathalie Terrones; Dominique Pechaud; Sylvie Surel; Jean-François Côté; Frédérique Peschaud; David Capper; Hélène Blons; Ute Zimmermann; Thierry Clerici; Philippe Saiag; Jean-François Emile
Journal:  J Mol Diagn       Date:  2012-11-15       Impact factor: 5.568

9.  BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma.

Authors:  Sonika Dahiya; Devon H Haydon; David Alvarado; Christina A Gurnett; David H Gutmann; Jeffrey R Leonard
Journal:  Acta Neuropathol       Date:  2013-04-23       Impact factor: 17.088

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962
View more
  15 in total

Review 1.  The role of the immune system in neurofibromatosis type 1-associated nervous system tumors.

Authors:  Souvik Karmakar; Karlyne M Reilly
Journal:  CNS Oncol       Date:  2016-12-21

2.  Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma.

Authors:  Angela C Hirbe; Sonika Dahiya; Christopher A Miller; Tiandao Li; Robert S Fulton; Xiaochun Zhang; Sandra McDonald; Katherine DeSchryver; Eric J Duncavage; Jessica Walrath; Karlyne M Reilly; Haley J Abel; Melike Pekmezci; Arie Perry; Timothy J Ley; David H Gutmann
Journal:  Clin Cancer Res       Date:  2015-04-29       Impact factor: 12.531

3.  TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors.

Authors:  Hendrikus J Dubbink; Hannah Bakels; Edward Post; Ellen C Zwarthoff; Robert M Verdijk
Journal:  J Neurooncol       Date:  2014-07-18       Impact factor: 4.130

Review 4.  Genetic Events and Signaling Mechanisms Underlying Schwann Cell Fate in Development and Cancer.

Authors:  Harish N Vasudevan; Calixto-Hope G Lucas; Javier E Villanueva-Meyer; Philip V Theodosopoulos; David R Raleigh
Journal:  Neurosurgery       Date:  2021-01-13       Impact factor: 4.654

5.  Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST.

Authors:  Hsiang-Chih Lu; Vanessa Eulo; Anthony J Apicelli; Melike Pekmezci; Yu Tao; Jingqin Luo; Angela C Hirbe; Sonika Dahiya
Journal:  Oncotarget       Date:  2018-05-01

6.  A clinically and genomically annotated nerve sheath tumor biospecimen repository.

Authors:  Kai Pollard; Jineta Banerjee; Xengie Doan; Jiawan Wang; Xindi Guo; Robert Allaway; Shannon Langmead; Bronwyn Slobogean; Christian F Meyer; David M Loeb; Carol D Morris; Allan J Belzberg; Jaishri O Blakeley; Fausto J Rodriguez; Justin Guinney; Sara J C Gosline; Christine A Pratilas
Journal:  Sci Data       Date:  2020-06-19       Impact factor: 6.444

Review 7.  From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor.

Authors:  Kathryn M Lemberg; Jiawan Wang; Christine A Pratilas
Journal:  Genes (Basel)       Date:  2020-06-24       Impact factor: 4.096

Review 8.  BRAF mutation and its inhibitors in sarcoma treatment.

Authors:  Haotian Liu; Nahar Nazmun; Shafat Hassan; Xinyue Liu; Jilong Yang
Journal:  Cancer Med       Date:  2020-05-31       Impact factor: 4.452

9.  Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.

Authors:  Abigail Godec; Reyka Jayasinghe; John S A Chrisinger; Bethany Prudner; Tyler Ball; Yuxi Wang; Divya Srihari; Madhurima Kaushal; Hilary Dietz; Xiaochun Zhang; Melike Pekmezci; Sonika Dahiya; Yu Tao; Jinqin Luo; Brian A Van Tine; Li Ding; David H Gutmann; Angela C Hirbe
Journal:  Neurooncol Adv       Date:  2019-09-10

Review 10.  The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation.

Authors:  Andrew S Brohl; Elliot Kahen; Sean J Yoder; Jamie K Teer; Damon R Reed
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.